Peer-reviewed veterinary case report
Involvement of serotonin receptor 7 in synaptic dysfunctions in a mouse model of autism spectrum disorder.
- Journal:
- European journal of pharmacology
- Year:
- 2026
- Authors:
- Filiz, Kardelen Dalim et al.
- Affiliation:
- Department of Pharmacy · Italy
- Species:
- rodent
Abstract
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social interaction and communication, repetitive behaviors, and altered brain plasticity. Emerging evidence indicates that impairment in the serotonergic system, particularly involving serotonin receptor 7 (5-HTreceptor), plays a crucial role in ASD pathophysiology. In this study, we investigated the synaptic alterations in the brain of juvenile and adult BTBR T + Itpr3tf/J (BTBR) mice, a well-established ASD model, emphasizing the pivotal role of 5-HTreceptor in regulating synaptic morphology and functions. Our analyses revealed a significant alteration of pre- and post-synaptic proteins expression, impaired synaptic protein synthesis, and abnormal dendritic spine morphology in the brain cortex of BTBR mice. These synaptic deficits were accompanied by a reduction in 5-HTreceptor expression in brain cortex synaptosomes of BTBR mice, underscoring the importance of 5-HTreceptor in maintaining synaptic homeostasis. Remarkably, pharmacological activation of 5-HTreceptor with the selective agonist LP-211 restored synaptic protein synthesis and ameliorated dendritic spine abnormalities in brain cortex of BTBR mice. Altogether, our findings provide new insights into the molecular underpinnings of ASD, suggesting that targeting the 5-HTreceptor is a promising therapeutic approach to address synaptic dysfunctions in neurodevelopmental disorders.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/41763482/